HLB Life Science Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 12, 2021 at 02:12 am EST
Share
HLB Life Science Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 13,725.3 million compared to KRW 19,346.86 million a year ago. Net income was KRW 47,335.03 million compared to KRW 11,734.59 million a year ago. Basic earnings per share from continuing operations was KRW 503 compared to KRW 125 a year ago. Diluted earnings per share from continuing operations was KRW 503 compared to KRW 125 a year ago. Basic earnings per share was KRW 503 compared to KRW 125 a year ago.
For the nine months, sales was KRW 617.45 million compared to KRW 255.54 million a year ago. Net income was KRW 15,244.6 million compared to net loss of KRW 12,154.9 million a year ago. Basic earnings per share from continuing operations was KRW 162 compared to basic loss per share from continuing operations of KRW 129 a year ago. Diluted earnings per share from continuing operations was KRW 162 compared to diluted loss per share from continuing operations of KRW 129 a year ago. Basic earnings per share was KRW 162 compared to basic loss per share of KRW 129 a year ago.
HLB Life Science Co., Ltd. is a Korea-based company mainly engaged in the sale of pharmaceuticals. Along with subsidiaries, the Company operates its business through four segments. The Pharmaceutical Distribution segment is involved in the sale of pharmaceuticals and raw materials through SHINWHAADVANCE.CO.LTD. The Energy Business segment is engaged in energy service company (ESCO) business. It is equipped with equipments, assets and technical personnel to engage in energy saving investment business. The Bio Development segment is engaged in the development of extracorporeal circulation type bio space, hepatocyte treatment agents and hemostatic agents. The main products include anticancer drugs such as Tegatrabetan and Seclidemstat. The Other Business segment is involved in the investment of small business start-ups and venture businesses, as well as manufacturing and sale of light emitting diode (LED) products.
HLB LIFE SCIENCE CO., LTD. 
